BOMBERG
15.7.2021 11:14:08 CEST | Business Wire | Press release
True to its rebellious spirit, BOMBERG has launched the first watch ever to incorporate CBD leaves extract: "BB01 Automatic Cure the BullDog ".
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210715005041/en/
BOMBERG connections to CBD are rooted in the relationship nurtured over the years with dogs.
Since the BOMBERG launch in 2012 the bulldogs, Bolt in Mexico and Duke & Paulina in Switzerland, have always been the official brand ambassadors and mascot.
In 2015 BOMBERG partnered with “Barry Foundation ”, the world’s oldest breeder of St. Bernards and in 2020 with the campaign “Take care of me” supported the “Black Jaguar-White Tiger Foundation ”.
After Bolt suffered an episode of stress, BOMBERG got in touch with “Bouledogue Attitude Foundation ”, in Switzerland, that recommended CBD-based food for its natural properties that help relieve anxiety as well as create a stronger nervous system.
Bolt recovered quickly and helps now spreading the word about BB-01 Automatic Cure the BullDog , the world’s first watch ever containing 100% natural CBD with 0% THC.
Treading an unbeaten path away from the roots of traditional lifestyle industry, BOMBERG embraces the free and insurgent spirit of millions of people around the world who dare to be different and to create their own maverick rules.
The new BB01 Automatic Cure the BullDog combines BOMBERG revolutionary, free and adventurous soul with an outstanding concept and a phenomenal design.
The dial features the instantly recognisable CBD indica plant with its seven serrated leaves and a powerful Super-LumiNova that makes the watch always readable.
BB01 Automatic Cure the BullDog presents real CBD indica leaves extract inside the dial and a strap made of authentic hemp, produced by our partner in the United States, following the strictest sustainability and natural production standards.
BB-01 Automatic Cure the BullDog is the ultimate symbol of audacity signed by BOMBERG .
Technical details:
Reference: |
CT43ASS.30-1.11 |
||
Movement: |
Automatic 3 hands, Sellita SW200, 38 hours power reserve |
||
Case: |
43mm, stainless steel case |
||
|
Outer ring with CBD leaves pattern |
||
Dial: |
Strong Superluminova on the Indica leaf |
||
|
Real organic US hemp inside the dial below the Indica leaf |
||
Crystal: |
Sapphire with anti reflective coating |
||
WR: |
50m |
||
Strap: |
Fabric strap made with US hemp |
||
Buckle: |
Stainless steel folding clasp |
||
|
RRP CHF, VAT excl. CHF 1’790 |
||
|
Quantity SPECIAL EDITION with limited production |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210715005041/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release
Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release
Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
